rapt

RAPT Therapeutics, Inc. Rings the Opening Bell in Celebration of its IPO

Date & Time
Location

ABOUT THIS EVENT

RAPT Therapeutics, Inc. (Nasdaq: RAPT), a clinical stage immunology-based biopharmaceutical company focused on discovering, developing and commercializing oral small molecule therapies for patients with significant unmet needs in oncology and inflammatory diseases, visited the Nasdaq MarketSite in Times Square.

In honor of the occasion, Brian Wong, M.D., Ph.D., President & CEO, rang the Opening Bell.

Nasdaq watch

See what's playing at Nasdaq

WATCH NOW ->